Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gül Kozalak"'
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 111 (2023)
Multiple myeloma is a hematological cancer type. For its treatment, Bortezomib has been widely used. However, drug resistance to this effective chemotherapeutic has been developed for various reasons. 2D cell cultures and animal models have failed to
Externí odkaz:
https://doaj.org/article/344801d30660406b9cff086136c57319
Autor:
Ghazaleh Gharib, İsmail Bütün, Zülâl Muganlı, Gül Kozalak, İlayda Namlı, Seyedali Seyedmirzaei Sarraf, Vahid Ebrahimpour Ahmadi, Erçil Toyran, Andre J. van Wijnen, Ali Koşar
Publikováno v:
Biosensors, Vol 12, Iss 11, p 1023 (2022)
Both passive and active microfluidic chips are used in many biomedical and chemical applications to support fluid mixing, particle manipulations, and signal detection. Passive microfluidic devices are geometry-dependent, and their uses are rather lim
Externí odkaz:
https://doaj.org/article/4bac5c8c4f9b49d79c277424e350f664
Publikováno v:
SOUTHERN JOURNAL OF SCIENCES. 30:32-46
Background: Coronavirus Disease-2019 (COVID-19) appears in individuals asymptomatically and in various symptomatic forms. Symptomatic diversity can result in diagnosis failures, hospitalization, admission to intensive care, multi-organ failure, and d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98936985b7ef1d9b674299151e8728db
https://doi.org/10.48141/sjs.v30.n34.2022.04_atceken_pgs_32_46.pdf
https://doi.org/10.48141/sjs.v30.n34.2022.04_atceken_pgs_32_46.pdf
Autor:
Gül KOZALAK, Nazente Atçeken
Publikováno v:
Periódico Tchê Química. 19:35-47
Background: Chronic inflammatory diseases are the long-term response of the organism to any stimulus. Crohn's (CD) and Celiac (CeD) diseases are among chronic inflammatory diseases, and both cause chronic inflammation in the intestines. Both diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44cb0689a544c40cc1cf7a10b42a5c14
https://doi.org/10.52571/ptq.v19.n41.2022.04_gul_pgs_35_47.pdf
https://doi.org/10.52571/ptq.v19.n41.2022.04_gul_pgs_35_47.pdf
Autor:
Andre J. Van Wijnen, Zülal Muganlı, Seyedali Seyedmirzaei Sarraf, Gül KOZALAK, İsmail Bütün, Vahid Ebrahimpour Ahmadi, İlayda Namlı, Ercil Toyran, Ghazaleh Gharib, Ali Kosar
Publikováno v:
Biosensors. 12(11)
Both passive and active microfluidic chips are used in many biomedical and chemical applications to support fluid mixing, particle manipulations, and signal detection. Passive microfluidic devices are geometry-dependent, and their uses are rather lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4203b9c844f4384862158288db2c0bf
https://pubmed.ncbi.nlm.nih.gov/36421141
https://pubmed.ncbi.nlm.nih.gov/36421141
Autor:
Gül KOZALAK, Oksuzoglu, Emine
Publikováno v:
Web of Science
Multiple myeloma (MM) is a hematologic cancer characterized by the accumulation of malignant plasma cells. Bortezomib is the most effective chemotherapeutic drug used in treatment. However, drug resistance hinders efficient chemotherapy. One of the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::61f6e8ac28f766e2c254387ad5d69e42
https://hdl.handle.net/20.500.12451/9153
https://hdl.handle.net/20.500.12451/9153
Autor:
Emine Oksuzoglu, Gül Kozalak
Background Multiple myeloma (MM), a malignancy of plasma cells, is the second most prevalent hematological cancer. Bortezomib is the most effective chemotherapeutic drug used in treatment. However, drug-resistance prevents success of chemotherapy. On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c46cf0c990ebd20579d95f35db6d3977
https://hdl.handle.net/20.500.12451/7966
https://hdl.handle.net/20.500.12451/7966
Autor:
Jane Ru Choi, Gül Kozalak, Ighli di Bari, Quratulain Babar, Zahra Niknam, Yousef Rasmi, Kar Wey Yong
Publikováno v:
Cancers. 14:2284
Cancer is one of the leading causes of death worldwide, and its incidence is steadily increasing. Although years of research have been conducted on cancer treatment, clinical treatment options for cancers are still limited. Animal cancer models have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2bb359534fcb431d0d04d20a3f2f468
https://doi.org/10.3390/cancers14092284
https://doi.org/10.3390/cancers14092284
Autor:
Gül KOZALAK
Publikováno v:
Gül KOZALAK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a3522a11df4fd502ed7fe3d5718c1a8d
https://publons.com/publon/50164670/
https://publons.com/publon/50164670/